| Macular Thickness |
Duration |
Alzer-Diamel Average ± SEM n = 25 |
Placebo Average ± SEM n = 24 |
P-Value |
| MT LE |
Start |
189.28 ± 10.26 |
181.48 ± 13.20 |
0.331 |
| 12 months |
178.94 ± 8.74 |
199.52 ± 13.30 |
0.291 |
|
| Change |
−10.33 ± 11.99 |
18.05 ± 8.94 |
0.016 |
|
| MT RE |
Start |
184.06 ± 11.76 |
184.65 ± 14.16 |
0.610 |
| 12 months |
171.81 ± 10.47 |
210.63 ± 14.96 |
0.066 |
|
| Change |
−13.07 ± 12.64 |
15.45 ± 13.26 |
0.463 |
|
| VA LE |
Start |
0.95 ± 0.03 |
0.93 ± 0.03 |
0.300 |
| 12 months |
0.94 ± 0.04 |
0.092 ± 0.03 |
0.153 |
|
| Change |
−0.008 ± 0.03 |
−0.013 ± 0.016 |
0.988 |
|
| VA RE |
Start |
0.97 ± 0.03 |
0.95 ± 0.04 |
0.532 |
| 12 months |
0.97 ± 0.02 |
0.95 ± 0.04 |
0.966 |
|
| Change |
−0.004 ± 0.015 |
−0.008 ± 0.006 |
0.333 |